Precipio Net Income 2010-2025 | PRPO
Precipio net income from 2010 to 2025. Net income can be defined as company's net profit or loss after all revenues, income items, and expenses have been accounted for.
| Precipio Annual Net Income (Millions of US $) |
|
|---|---|
| 2024 | $-4 |
| 2023 | $-6 |
| 2022 | $-12 |
| 2021 | $-9 |
| 2020 | $-14 |
| 2019 | $-13 |
| 2018 | $-20 |
| 2017 | $-33 |
| 2016 | $-4 |
| 2015 | $-34 |
| 2014 | $-15 |
| 2013 | $-17 |
| 2012 | $-9 |
| 2011 | $-11 |
| 2010 | $-3 |
| 2009 | $-2 |
| Precipio Quarterly Net Income (Millions of US $) |
|
|---|---|
| 2025-03-31 | $-1 |
| 2024-12-31 | $0 |
| 2024-09-30 | $-1 |
| 2024-06-30 | $-1 |
| 2024-03-31 | $-2 |
| 2023-12-31 | $1 |
| 2023-09-30 | $-1 |
| 2023-06-30 | $-2 |
| 2023-03-31 | $-3 |
| 2022-12-31 | $-2 |
| 2022-09-30 | $-3 |
| 2022-06-30 | $-2 |
| 2022-03-31 | $-5 |
| 2021-12-31 | $-2 |
| 2021-09-30 | $-2 |
| 2021-06-30 | $-3 |
| 2021-03-31 | $-1 |
| 2020-12-31 | $-2 |
| 2020-09-30 | $-3 |
| 2020-06-30 | $-2 |
| 2020-03-31 | $-7 |
| 2019-12-31 | $-4 |
| 2019-09-30 | $-2 |
| 2019-06-30 | $-6 |
| 2019-03-31 | $-2 |
| 2018-12-31 | $-7 |
| 2018-09-30 | $-4 |
| 2018-06-30 | $-3 |
| 2018-03-31 | $-6 |
| 2017-12-31 | $-13 |
| 2017-09-30 | $-10 |
| 2017-06-30 | $-9 |
| 2017-03-31 | $-1 |
| 2016-12-31 | $1 |
| 2016-09-30 | $0 |
| 2016-06-30 | $0 |
| 2016-03-31 | $-4 |
| 2015-12-31 | $-20 |
| 2015-09-30 | $-8 |
| 2015-06-30 | $-3 |
| 2015-03-31 | $-3 |
| 2014-12-31 | $-6 |
| 2014-09-30 | $0 |
| 2014-06-30 | $-4 |
| 2014-03-31 | $-4 |
| 2013-12-31 | $-4 |
| 2013-09-30 | $-6 |
| 2013-06-30 | $-3 |
| 2013-03-31 | $-4 |
| 2012-12-31 | $-2 |
| 2012-09-30 | $-3 |
| 2012-06-30 | $-1 |
| 2012-03-31 | $-3 |
| 2011-12-31 | $0 |
| 2011-09-30 | $-2 |
| 2011-06-30 | $-6 |
| 2011-03-31 | $-3 |
| 2010-12-31 | $-1 |
| 2010-09-30 | $-1 |
| 2010-06-30 | $-1 |
| 2010-03-31 | $0 |
| 2009-12-31 | $0 |
| 2009-09-30 | $0 |
| 2009-06-30 | $-1 |
| 2009-03-31 | $-1 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $0.014B | $0.019B |
| Precipio Inc. has built a platform designed to eradicate the problem of misdiagnosis by harnessing the intellect, expertise and technology developed within academic institutions and delivering quality diagnostic information to physicians and their patients worldwide. Through its collaborations with world-class academic institutions specializing in cancer research, diagnostics and treatment, Precipio offers a new standard of diagnostic accuracy enabling the highest level of patient care. Precipio Inc., formerly known as Transgenomic Inc., is based in Omaha, United States of America. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $45.506B | 58.15 |
| Hims & Hers Health (HIMS) | United States | $12.660B | 131.53 |
| Tempus AI (TEM) | United States | $9.553B | 0.00 |
| IRhythm Technologies (IRTC) | United States | $4.485B | 0.00 |
| Inspire Medical Systems (INSP) | United States | $4.076B | 63.69 |
| Privia Health (PRVA) | United States | $2.775B | 189.67 |
| Enovis (ENOV) | United States | $1.788B | 9.97 |
| Clover Health Investments (CLOV) | United States | $1.598B | 0.00 |
| Schrodinger (SDGR) | United States | $1.586B | 0.00 |
| Phreesia (PHR) | United States | $1.457B | 0.00 |
| Omnicell (OMCL) | United States | $1.423B | 25.10 |
| Azenta (AZTA) | United States | $1.223B | 56.85 |
| 10x Genomics (TXG) | United States | $1.173B | 0.00 |
| Claritev (CTEV) | United States | $0.632B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.631B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.593B | 0.00 |
| Talkspace (TALK) | United States | $0.534B | 159.50 |
| Veradigm (MDRX) | United States | $0.466B | 0.00 |
| Standard BioTools (LAB) | United States | $0.384B | 0.00 |
| TruBridge (TBRG) | United States | $0.360B | 797.67 |
| Outset Medical (OM) | United States | $0.311B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.264B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.261B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.200B | 0.00 |
| Pulmonx (LUNG) | United States | $0.137B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.136B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.125B | 0.00 |
| American Well (AMWL) | United States | $0.105B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.100B | 0.00 |
| CareCloud (CCLD) | United States | $0.085B | 3.26 |
| 111 (YI) | China | $0.071B | 0.00 |
| HeartBeam (BEAT) | United States | $0.057B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.053B | 0.00 |
| Zepp Health (ZEPP) | Netherlands | $0.037B | 0.00 |
| Zhongchao (ZCMD) | China | $0.029B | 0.00 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.026B | 0.00 |
| Streamline Health Solutions (STRM) | United States | $0.022B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.016B | 0.00 |
| MSP Recovery (MSPR) | United States | $0.010B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.010B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.008B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.004B | 0.00 |
| Movano (MOVE) | United States | $0.004B | 0.00 |
| HeartSciences (HSCS) | United States | $0.004B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.004B | 0.00 |
| Evaxion - (EVAX) | Denmark | $0.003B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.000B | 0.00 |
| Future Health ESG (FHLT) | United States | $0.000B | 0.00 |